White G C, Zeitler K D, Lesesne H R, McMillan C W, Warren M S, Roberts H R, Blatt P M
Blood. 1982 Dec;60(6):1259-62.
Recent studies in multiply transfused patients with hemophilia A and persistent liver function abnormalities have shown a high incidence of chronic active hepatitis. The purpose of the present study was to determine the severity of liver disease in multiply transfused patients with intermittent liver enzyme abnormalities. Fifteen patients with elevated enzymes on two or three out of four determinations at 6-mo intervals were studied. None had signs or symptoms of chronic liver disease. Thirteen had serologic evidence of prior exposure to the hepatitis B virus. Liver biopsy performed on these patients after replacement therapy with factor VIII showed chronic persistent hepatitis or other mild forms of liver disease in 14 of the 15 patients. Patients with chronic persistent hepatitis had significantly higher mean liver enzymes at time of biopsy than patients with milder forms of hepatic inflammation, but there was no relationship between liver histology and hepatitis B serology or the amount of factor VIII used in the 6 mo preceding biopsy. These findings support the continued use of factor VIII concentrates in patients with hemophilia.
近期针对多次输血的甲型血友病患者且伴有持续肝功能异常的研究表明,慢性活动性肝炎的发病率很高。本研究的目的是确定多次输血且伴有间歇性肝酶异常的患者的肝病严重程度。对15名患者进行了研究,这些患者在每隔6个月的4次检测中有2次或3次酶水平升高。无一例有慢性肝病的体征或症状。13例有既往接触过乙肝病毒的血清学证据。在用凝血因子VIII替代治疗后对这些患者进行肝脏活检,结果显示15例患者中有14例患有慢性持续性肝炎或其他轻度肝病形式。慢性持续性肝炎患者在活检时的平均肝酶水平显著高于炎症较轻的肝病患者,但肝脏组织学与乙肝血清学之间或活检前6个月使用的凝血因子VIII量之间并无关联。这些发现支持血友病患者继续使用凝血因子VIII浓缩剂。